Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.
about
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisTensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinomaPaxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic diseaseOverexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancerUsing protein microarray as a diagnostic assay for non-small cell lung cancerTalin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.Useful detection of CD147 (EMMPRIN) for pathological diagnosis of early hepatocellular carcinoma in needle biopsy samplesFocal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinomaExpression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer PatientsCD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-AnalysisCD147 immunoglobulin superfamily receptor function and role in pathologyDiverse roles for the paxillin family of proteins in cancer.Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.The role of EMMPRIN expression in ovarian epithelial carcinomas.MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells.Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.Molecular characteristics of fibrolamellar hepatocellular carcinoma.Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions.Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinomaPaxillin expression is closely linked to the pathogenesis, progression and prognosis of gastric carcinomas.Cellular responses and expression profiling of human bone marrow stromal cells stimulated with enamel matrix proteins in vitro.CD147 expression indicates unfavourable prognosis in prostate cancer.Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry.
P2860
Q26771312-AF804520-ED76-49D3-B83B-93152F70A144Q28265813-632D6C27-8841-46E0-8195-433B0BBAAD4EQ28297509-085B5D3B-B56A-49D2-A33D-AAC218E992C2Q30538395-3146707E-2174-47BB-A90A-922FC82F06A1Q30796772-C426DAE4-4CE0-473C-9BB0-4757D1957D20Q33718142-D9B3FEEE-96C6-4CE5-8005-EBE21A91E5C1Q34224698-86AD8CBD-D2FB-4B4D-AD3C-66DB0693BA01Q34399693-2B7235DF-3044-487D-8ACD-A49D6DC2EC6DQ34493542-9A4CFD09-7FA6-4480-A9BC-F81A7AF44055Q34500644-0CA8C7A8-6997-4395-9F3F-165105B22C3AQ34979073-E124C51F-4476-4CA4-AB15-EADBD5DCB144Q35801303-4C496090-C317-4C07-83C5-8E004CED72D7Q35871428-5DCBF23E-E80F-47C9-9DD9-1994F53B904DQ36339219-D91F0EC7-8E1F-418A-8FBD-98C6758EB9AAQ36398938-A2D3C645-76D5-4B9C-B212-A2CAE9A83663Q36443392-3450E51A-E017-4A90-9C1B-D9F850EE427CQ36611964-34A2109C-99D7-4BFE-9C09-1D0AF988EE12Q37505550-3AC2DB57-4B28-4F0B-A589-78BECF58AD9BQ38875145-C082EF3F-ACC1-4245-A3A0-DFBBE708CA54Q38949683-F57F9818-1421-4BE2-95ED-376D55F45E07Q39218321-11974CE7-9E92-4673-91E0-84E9529B67FDQ39698021-574DA09A-5290-4D9D-BF04-2D3CB388FE43Q40013305-071C0E34-DBCA-4FFB-975C-71E99A027C0AQ40055042-FB895B18-E879-476D-8EFA-E7C3729B091CQ40281137-9B37A874-A7DD-41FB-B52C-7F4043C689BEQ41620442-F16FA2CB-E651-435D-B27E-732BFAA48F1FQ42095789-1871DF6E-F0D3-4AF8-85DC-6877200A2B21Q43239541-F494BBFE-3127-4F45-8AE1-A6ED07ABD5D5Q43968053-23C85C7A-3FAE-4E0F-B9FD-60BE4C67495FQ45048902-4838F2F6-370D-4B95-A28E-91818F005F48Q50157232-1806C0A2-82FF-43B2-A8DC-BE5B2E74DAB1
P2860
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinicopathological significan ...... N in hepatocellular carcinoma.
@ast
Clinicopathological significan ...... N in hepatocellular carcinoma.
@en
type
label
Clinicopathological significan ...... N in hepatocellular carcinoma.
@ast
Clinicopathological significan ...... N in hepatocellular carcinoma.
@en
prefLabel
Clinicopathological significan ...... N in hepatocellular carcinoma.
@ast
Clinicopathological significan ...... N in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Clinicopathological significan ...... N in hepatocellular carcinoma.
@en
P2093
De-Rong Xie
Hai-Gang Li
Hong-Hao Li
Xi-Ming Shen
Yun-Jie Zeng
P2860
P304
P356
10.3748/WJG.V11.I10.1445
P407
P577
2005-03-01T00:00:00Z